Published in Arterioscler Thromb Vasc Biol on September 30, 2004
Autophagy links inflammasomes to atherosclerotic progression. Cell Metab (2012) 2.08
Oxidized lipids activate autophagy in a JNK-dependent manner by stimulating the endoplasmic reticulum stress response. Redox Biol (2013) 1.14
Autophagy in cardiovascular biology. J Clin Invest (2015) 1.14
The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones. Neurobiol Dis (2006) 1.13
Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes. Cell Physiol Biochem (2013) 1.08
Interactions between cell death induced by statins and 7-ketocholesterol in rabbit aorta smooth muscle cells. Br J Pharmacol (2008) 1.07
HDLs inhibit endoplasmic reticulum stress and autophagic response induced by oxidized LDLs. Cell Death Differ (2010) 1.06
Oxidized low-density lipoproteins upregulate proline oxidase to initiate ROS-dependent autophagy. Carcinogenesis (2009) 1.00
Macrophage autophagy in atherosclerosis. Mediators Inflamm (2013) 1.00
7-Ketocholesterol induces autophagy in vascular smooth muscle cells through Nox4 and Atg4B. Am J Pathol (2013) 0.99
Self-eating in the plaque: what macrophage autophagy reveals about atherosclerosis. Trends Endocrinol Metab (2014) 0.98
The role of autophagy in vascular biology. Circ Res (2015) 0.96
Autophagy plays a protective role in free cholesterol overload-induced death of smooth muscle cells. J Lipid Res (2010) 0.93
Oxidative and endoplasmic reticulum stresses mediate apoptosis induced by modified LDL in human retinal Müller cells. Invest Ophthalmol Vis Sci (2012) 0.93
Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis. Autophagy (2015) 0.92
Implications of autophagy for vascular smooth muscle cell function and plasticity. Free Radic Biol Med (2013) 0.88
The role of oxidative stress and autophagy in atherosclerosis. Oxid Med Cell Longev (2015) 0.86
Autophagy in the fat body cells of the cave cricket Troglophilus neglectus Krauss, 1878 (Rhaphidophoridae, Saltatoria) during overwintering. Protoplasma (2015) 0.83
Autophagy: an emerging therapeutic target in vascular diseases. Br J Pharmacol (2015) 0.82
Defective autophagosome trafficking contributes to impaired autophagic flux in coronary arterial myocytes lacking CD38 gene. Cardiovasc Res (2014) 0.82
Cytotoxic oxysterols induce caspase-independent myelin figure formation and caspase-dependent polar lipid accumulation. Histochem Cell Biol (2007) 0.81
ORMDL3 contributes to the risk of atherosclerosis in Chinese Han population and mediates oxidized low-density lipoprotein-induced autophagy in endothelial cells. Sci Rep (2015) 0.80
Autophagy in atherosclerosis: a phenomenon found in human carotid atherosclerotic plaques. Chin Med J (Engl) (2015) 0.78
Autophagy dysfunction and regulatory cystatin C in macrophage death of atherosclerosis. J Cell Mol Med (2016) 0.77
Mitophagy acts as a safeguard mechanism against human vascular smooth muscle cell apoptosis induced by atherogenic lipids. Oncotarget (2016) 0.76
Autophagy Induction Protects Against 7-Oxysterol-induced Cell Death via Lysosomal Pathway and Oxidative Stress. J Cell Death (2016) 0.76
Autophagy is associated with cell fate in the process of macrophage-derived foam cells formation and progress. J Biomed Sci (2016) 0.76
Stimulation of Akt poly-ubiquitination and proteasomal degradation in P388D1 cells by 7-ketocholesterol and 25-hydroxycholesterol. Arch Biochem Biophys (2009) 0.76
Eating the Dead to Keep Atherosclerosis at Bay. Front Cardiovasc Med (2017) 0.75
Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice. Arterioscler Thromb Vasc Biol (2008) 2.72
Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest (2003) 2.66
Induction of atherosclerotic plaque rupture in apolipoprotein E-/- mice after adenovirus-mediated transfer of p53. Circulation (2002) 2.62
Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler Thromb Vasc Biol (2005) 2.27
Western array analysis of human atherosclerotic plaques: downregulation of apoptosis-linked gene 2. Cardiovasc Res (2003) 2.09
Immunohistochemical characterisation of dendritic cells in human atherosclerotic lesions: possible pitfalls. Pathology (2011) 2.07
Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability. Cardiovasc Res (2006) 1.87
Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice. J Clin Invest (2009) 1.83
Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation (2002) 1.78
Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circ Res (2009) 1.69
Platelet phagocytosis and processing of beta-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis. Circ Res (2002) 1.68
Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms. Am J Physiol Heart Circ Physiol (2005) 1.49
Mitochondrial uncoupling protein 2 mediates temperature heterogeneity in atherosclerotic plaques. Cardiovasc Res (2007) 1.45
In situ detection of starvation-induced autophagy. J Histochem Cytochem (2005) 1.38
Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol (2003) 1.34
Autophagy in cardiovascular disease. Trends Mol Med (2007) 1.31
Selective clearance of macrophages in atherosclerotic plaques by autophagy. J Am Coll Cardiol (2007) 1.31
Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI. Cardiovasc Res (2003) 1.29
Autophagy in disease: a double-edged sword with therapeutic potential. Clin Sci (Lond) (2009) 1.26
Detection of autophagy in tissue by standard immunohistochemistry: possibilities and limitations. Autophagy (2006) 1.18
Fn14-Fc fusion protein regulates atherosclerosis in ApoE-/- mice and inhibits macrophage lipid uptake in vitro. Arterioscler Thromb Vasc Biol (2009) 1.18
Nucleofection as an efficient nonviral transfection method for human monocytic cells. Biotechnol Lett (2003) 1.18
Autophagy in atherosclerosis. Curr Atheroscler Rep (2008) 1.13
Autophagy in atherosclerosis: a potential drug target for plaque stabilization. Arterioscler Thromb Vasc Biol (2011) 1.10
Gastrointestinal function regulation by nitrergic efferent nerves. Pharmacol Rev (2005) 1.09
Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved. Br J Pharmacol (2003) 1.05
Gene expression profiling of apoptosis-related genes in human atherosclerosis: upregulation of death-associated protein kinase. Arterioscler Thromb Vasc Biol (2002) 1.05
Alteration of the purinergic modulation of enteric neurotransmission in the mouse ileum during chronic intestinal inflammation. Br J Pharmacol (2003) 1.02
Immunohistochemical analysis of macroautophagy: recommendations and limitations. Autophagy (2012) 1.02
Polycyclic aromatic hydrocarbons induce an inflammatory atherosclerotic plaque phenotype irrespective of their DNA binding properties. FASEB J (2005) 1.01
Chronic exposure to the carcinogenic compound benzo[a]pyrene induces larger and phenotypically different atherosclerotic plaques in ApoE-knockout mice. Am J Pathol (2004) 1.01
Selective depletion of macrophages in atherosclerotic plaques via macrophage-specific initiation of cell death. Trends Cardiovasc Med (2007) 1.00
Everolimus-induced mTOR inhibition selectively depletes macrophages in atherosclerotic plaques by autophagy. Autophagy (2007) 1.00
Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality? Autoimmun Rev (2013) 0.99
Increased vulnerability of pre-existing atherosclerosis in ApoE-deficient mice following adenovirus-mediated Fas ligand gene transfer. Atherosclerosis (2005) 0.97
Effect of inhibition of inducible nitric oxide synthase and guanylyl cyclase on endotoxin-induced delay in gastric emptying and intestinal transit in mice. Shock (2002) 0.96
mRNA but not plasmid DNA is efficiently transfected in murine J774A.1 macrophages. Biochem Biophys Res Commun (2005) 0.95
Western blot analysis of a limited number of cells: a valuable adjunct to proteome analysis of paraffin wax-embedded, alcohol-fixed tissue after laser capture microdissection. J Pathol (2004) 0.94
In vivo temperature heterogeneity of atherosclerotic plaques is determined by plaque composition. Circulation (2002) 0.94
Proteasome inhibitor bortezomib promotes a rupture-prone plaque phenotype in ApoE-deficient mice. Basic Res Cardiol (2009) 0.94
Macrophages but not smooth muscle cells undergo benzyloxycarbonyl-Val-Ala-DL-Asp(O-Methyl)-fluoromethylketone-induced nonapoptotic cell death depending on receptor-interacting protein 1 expression: implications for the stabilization of macrophage-rich atherosclerotic plaques. J Pharmacol Exp Ther (2006) 0.94
Amino acid deprivation induces both apoptosis and autophagy in murine C2C12 muscle cells. Biotechnol Lett (2005) 0.92
Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis. Basic Res Cardiol (2013) 0.92
Toll-like receptor 7 stimulation by imiquimod induces macrophage autophagy and inflammation in atherosclerotic plaques. Basic Res Cardiol (2012) 0.92
Worms and the treatment of inflammatory bowel disease: are molecules the answer? Clin Dev Immunol (2008) 0.91
The protein synthesis inhibitor anisomycin induces macrophage apoptosis in rabbit atherosclerotic plaques through p38 mitogen-activated protein kinase. J Pharmacol Exp Ther (2009) 0.91
Necrotic cell death in atherosclerosis. Basic Res Cardiol (2011) 0.91
Selective removal of macrophages in atherosclerotic plaques as a pharmacological approach for plaque stabilization: benefits versus potential complications. Curr Vasc Pharmacol (2010) 0.90
Impaired fibrillin-1 function promotes features of plaque instability in apolipoprotein E-deficient mice. Circulation (2009) 0.89
Differential effect of the protein synthesis inhibitors puromycin and cycloheximide on vascular smooth muscle cell viability. J Pharmacol Exp Ther (2008) 0.89
Therapeutic strategies to deplete macrophages in atherosclerotic plaques. Br J Clin Pharmacol (2012) 0.88
RNA damage in human atherosclerosis: pathophysiological significance and implications for gene expression studies. RNA Biol (2005) 0.88
z-VAD-fmk-induced non-apoptotic cell death of macrophages: possibilities and limitations for atherosclerotic plaque stabilization. Autophagy (2006) 0.88